A Psychology Today essay broadens the menopause conversation to include identity and possible psychological growth, alongside individualised symptom care.
On October 25, 2026, Psychology Today published psychologist Debra M. Kawahara’s “Let’s Talk About Menopause.” The essay frames menopause as a biopsychosocial transition that involves emotional wellbeing and the circumstances of midlife rather than hormone levels alone.
Kawahara challenges a narrow account of menopause centred on reproductive health and hormonal symptoms. She is not announcing that an established medical standard has been overturned. Her argument is that understanding the transition requires attention to psychological experience and social circumstances alongside biological change.
In her account, hormonal shifts can contribute to mood changes and anxiety. Sleep disruption and concentration difficulties also belong in the discussion. Yet these experiences may coincide with caregiving responsibilities or career changes, while relationships and family roles are being reassessed.
The update is therefore one of perspective: a symptom-focused conversation need not exclude the wider life in which those symptoms occur.
Kawahara’s article brings several ideas into the same conversation:
This is an interpretive essay, not an original study or a clinical guideline. It supplies no dataset or estimate of how often psychological growth occurs, and it does not establish that menopause causes such growth. Kawahara acknowledges distress and impairment alongside positive experiences; her framing also cautions against assigning every midlife concern to hormones.
The distinction is useful: the essay offers a way to understand experience, while clinical guidance provides a separate foundation for discussing symptom care. Neither requires a woman to fit a single menopause story.
The most useful part of growth language is the permission it gives women to describe something other than decline. A clearer sense of personal limits can be worth discussing. So can changing priorities or a wish to spend time differently.
Kawahara’s account gives those experiences a place in the conversation. An editorial reading of her argument is that confidence and identity deserve attention without becoming achievements against which women are judged.
That distinction matters when positive framing turns into an expectation to transform. A woman need not turn disrupted sleep or emotional difficulty into a lesson about becoming a better version of herself. Support can be worthwhile without producing a reinvention story.
Nor does recognising a positive change require dismissing a difficult one. The conversation can hold questions about purpose alongside questions about symptoms. Refemina’s coverage of the wider factors associated with midlife psychological wellbeing offers a related perspective beyond hormone levels alone.
The practical emphasis is on making room for a woman’s own account, not deciding in advance whether her transition should be described as loss or growth.
Kawahara’s framing and ACOG’s clinical guidance serve different purposes, but they meet at the need for an individual account. Her essay supplies context. ACOG describes shared decision-making around hormone therapy based on symptoms and personal health considerations.
Together, they support conversations organised around several areas rather than a single explanation:
For readers whose concerns centre on emotional symptoms, Refemina’s guide to recognising when low mood needs professional attention offers a related starting point.
Kawahara identifies several resources that may help during the transition. These are best understood as categories of support to discuss, not a universal programme or a set of personal treatment instructions.
Psychological support and clinical assessment have complementary roles in this account. The practical implication is a broader conversation about care, with personal decisions made alongside qualified professionals.
This also avoids presenting emotional support as evidence that symptoms are merely psychological. Kawahara’s central argument is that biological change and lived circumstances should be understood together, not made to compete for credibility.
In a separate announcement on October 15, 2026, ACOG reported expanded clinical guidance covering vasomotor symptoms and difficulties with sleep and mood. That announcement concerns symptom management, not evidence that menopause produces psychological growth.
ACOG describes both hormone therapy and nonhormonal medication options. Its announcement also includes exercise and clinical hypnosis among nonpharmacologic approaches for relevant symptoms, alongside acupuncture. These options sit within a wider discussion of care rather than establishing one treatment route for every woman.
The distinction between the essay and the guidance keeps the article’s message grounded. Kawahara asks for a broader understanding of the transition. ACOG describes options for addressing symptoms through individualised care.
A wider menu is not a reason to collect treatments or assume that every option addresses the same concern. ACOG’s emphasis on symptoms and treatment goals keeps the focus on the person seeking care. For hormone therapy, its shared decision-making approach also includes medical history and the balance of benefits and risks.
ACOG also states that evidence does not support the safety or efficacy of phytoestrogens or herbal supplements for treating menopausal symptoms. Broadening menopause care therefore does not mean treating every wellness claim as equally credible.
The useful connection is between better understanding and appropriate support, not between a new account of identity and another product to buy.
Read together, Kawahara’s essay and ACOG’s guidance point toward consultations that address symptoms and personal circumstances while leaving room for confidence and identity within clinical care.
Psychological growth belongs in menopause coverage without becoming another expectation women must meet. When physical and personal changes unsettle a sense of identity, Refemina’s research-led editorial approach connects confidence with the wider experience of midlife and helps readers distinguish credible explanations from messages that reduce every concern to hormones or products.
Follow Refemina for research-led insights on menopause, strength, metabolism, nutrition, skin, intimacy and confidence through midlife. New articles turn complex topics into clear, useful context.
Keep learning about the changes that shape energy, strength, confidence and wellbeing through midlife.
Explore Resources